Patient safety is paramount, and vigilant oversight of all relevant data sources is essential. Jeyflex offers pharmacovigilance literature screening and monitoring services to help pharmaceutical companies detect safety signals early and maintain full regulatory compliance. Our comprehensive literature surveillance covers major international databases as well as regional publications, tailored to your specific product portfolio.
We follow a systematic and proactive approach to literature screening and monitoring to ensure that no safety signal goes unnoticed. Our methodology includes:
- Continuous review of international and regional publications
- Screening of peer-reviewed journals, conference proceedings, and relevant online sources
- Early detection of potential safety signals to protect patient health
- Regular reporting aligned with regulatory requirements
- Expertise in Pharmacovigilance: Our team has extensive experience in patient safety surveillance.
- Tailored Solutions: Services designed to match your product portfolio and regulatory environment.
- Compliance-Focused: Ensuring all findings meet global and local regulatory standards.
- Reliable Reporting: Detailed reports suitable for regulatory submissions.
Our services are designed to support organizations of all sizes:
- Startups: Simplified literature screening packages for early-stage products.
- Multinationals: Full-service literature screening & monitoring with multi-region coverage.
- Additional Services: Consulting, training, and auditing to ensure ongoing regulatory compliance and risk mitigation.
Service Details
Our solutions are tailored to meet your unique needs and requirements, whether you’re a small startup or a large multinational corporation. We offer a range of services, including, consulting, training, and auditing, to help you ensure that you are complying with relevant regulations and laws, and to minimize the risk of non-compliance.
FAQs About Pharmacovigilance Literature Screening
Local literature screening ensures that region-specific safety information, regulatory updates, and adverse event trends are captured. Many safety signals appear first in local journals, case reports, and regional publications before they reach global databases, making this step essential for effective pharmacovigilance.
Global literature monitoring gathers safety data from international databases and widely indexed journals, while local literature monitoring focuses on region-specific publications and regulatory sources. Both are essential to ensure complete and compliant pharmacovigilance surveillance.
The frequency of literature screening depends on the product’s risk profile and regulatory expectations. Many pharmaceutical companies conduct weekly or monthly screenings to identify new safety information promptly.
Yes. We provide audit-ready reports that list the databases searched, the search strings used, and the results, which are ready for inclusion in your Periodic Safety Update Reports (PSURs) and PBRERs.
Got your own Question? Here are some options:
Contact us to learn more about our comprehensive literature screening and monitoring services and how we can tailor our solutions to your pharmacovigilance needs and regulatory standards.